The Biopsy Devices Market Size was valued at USD 2.49
billion in 2022 and is projected to grow from USD 2.64 billion in 2023 to USD
4.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8%
during the forecast period (2023 - 2032).
The biopsy devices market continues to witness robust growth, driven by
rising cancer prevalence, advancements in minimally invasive procedures, and
expanding geriatric populations globally. With increasing demand for early and
accurate cancer diagnosis, biopsy devices play a pivotal role in oncology
diagnostics, prompting manufacturers to innovate and introduce technologically
advanced solutions. The market showcases a diverse landscape, encompassing core
biopsy, fine-needle aspiration, and vacuum-assisted biopsy devices. Moreover,
the adoption of advanced imaging technologies like MRI and CT scan further
bolsters market expansion. However, challenges such as stringent regulatory
frameworks and high costs hinder market penetration, necessitating strategic
collaborations and product diversification among industry players.
The global biopsy devices market is experiencing significant growth,
driven by the rising prevalence of cancer and the increasing demand for
minimally invasive procedures. Biopsy devices play a crucial role in the
diagnosis and treatment of various cancers, providing clinicians with tissue
samples for accurate analysis and diagnosis. Key components of the biopsy
devices market include biopsy needles, prostate biopsy instruments, and general
biopsy instruments.
Biopsy needles are one of the most commonly used
devices in the market, utilized for obtaining tissue samples from organs such
as the breast, liver, and prostate. These needles come in different sizes and
designs, including core biopsy needles and fine needle aspiration (FNA)
needles, catering to the specific requirements of different procedures.
Prostate biopsy instruments are particularly important in the diagnosis
and monitoring of prostate cancer, one of the most prevalent cancers among men
globally. These instruments enable urologists to obtain tissue samples from the
prostate gland for histological analysis, aiding in the detection and staging
of prostate cancer.
General biopsy instruments encompass a wide range of devices used across
various biopsy procedures, including forceps, brushes, and punches. These
instruments facilitate the extraction of tissue samples with precision and
minimal trauma to the surrounding tissues, ensuring accurate diagnosis and
minimizing patient discomfort.
The increasing adoption of advanced biopsy devices, coupled with
technological advancements such as ultrasound-guided biopsies and
robotic-assisted procedures, is further driving market growth. Additionally,
growing investments in healthcare infrastructure and rising awareness about the
importance of early cancer detection are contributing to the expansion of the
biopsy devices market globally. As the demand for minimally invasive biopsy
procedures continues to rise, the market for biopsy devices is expected to
witness sustained growth in the coming years.
Segmentation
The Global Biopsy Devices Market has been
segmented based on product type, application,
and end user.
By product type, the global biopsy devices market has been segmented into biopsy guns, biopsy
guidance system, biopsy needles, forceps, and
others.
By application, the global biopsy devices market has been segmented into bone marrow biopsy, surgical biopsy, skin biopsy, needle biopsy, Cancer
Diagnosis, and others.
By end user, the global biopsy devices market has been segmented into hospitals, specialty clinics, diagnostic
centers, academic & research institutes, and
others.
Regional Analysis
By region, the global biopsy devices market has been segmented into the Americas, Asia Pacific
(APAC), Europe, and the Middle East & Africa (MEA).
The Americas account for the most significant
share of the global biopsy devices
market. High prevalence of oncology diseases generate high demand for cancer
screening and consequently drive the market for biopsy devices. High healthcare
expenditure, the existence of key players
in the region and extensive use of technologically advanced biopsy devices in
the region support the growth of the market. North America is leading the
Americas market and is anticipated to reach USD 2.4 Bn by the end of 2022.
Europe is the second largest market for biopsy devices. High
healthcare expenditure and high expenditure on healthcare infrastructure boost
the growth of the market.
APAC is on its path to emerge as the fastest
growing market for biopsy devices.
Surging prevalence of cancer, growing awareness which has led to increased
demand for cancer screening, and expansion of healthcare budget in emerging
economies are factors substantiating the growth of the APAC market. In addition, the governments in the region are
endeavoring towards raising awareness and encouraging individuals to undertake
cancer screening which is acting as a growth influencer.
Competitive Landscape
The Biopsy Devices
companies include Focal Therapeutics, Inc., C. R. Bard, Inc. Creganna, Scion Medical Technologies,
LLC. (UK), BD, Integra LifeSciences Corporation, Hologic, Inc., Argon Medical
Devices, Inc., Precision Biopsy, LLC, Cook Medical, and Leica Biosystems.
Related Report
Laser
Resurfacing Market Research Report – Global forecast till 2030
Chordoma
Disease Market Research Report - Forecast to 2032
For More Information, Please
Visit @ Market
Research Future
Comments
Post a Comment